Debbie S Deben

4PUBLICATIONS
4CO-AUTHORS
Nanotoxicology, health and safetyRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 26, 2024
Early therapeutic drug monitoring helps to identify inflammatory bowel disease patients with a high risk to fail thiopurine treatment.

Debbie S Deben, Bjorn Winkens, Sofia A W van Moorsel

|Oct 27, 2023
Implications of Tioguanine Dosing in IBD Patients with a TPMT Deficiency.

Debbie S Deben, Luc J J Derijks, Bianca J C van den Bosch

|Oct 01, 2021
Rac1/pSTAT3 expression: A pharmacodynamic marker panel as a first step toward optimization of thiopurine therapy in inflammatory bowel disease patients.

Debbie S Deben, Arjan J van Adrichem, Roosmarie Drent

Pageof 1